PHOTO ADVISORY -- FDA Approves Nexavar(R) for Treatment of Patients with Advanced Kidney Cancer
21 Diciembre 2005 - 10:55AM
PR Newswire (US)
Editors are advised that a high-resolution photo is available to
accompany the news release, NYTU092, FDA Approves Nexavar(R) for
Treatment of Patients with Advanced Kidney Cancer, issued yesterday
by Bayer Pharmaceuticals Corporation and Onyx Pharmaceuticals, Inc.
Caption: Nexavar(R) (sorafenib) tablets received U.S. FDA approval
for the treatment of patients with advanced kidney cancer. Nexavar
is an oral anti-cancer drug with a recommended dose of 400 mg (two
200 mg pills) taken twice daily. For Nexavar prescribing
information, visit http://www.nexavar.com/ or call 1.866.NEXAVAR
(1.866.639.2827). (PRNewsFoto) Members of the media may download
the photo at no charge from the following online archives: --
NewsCom: http://www.newscom.com/cgi-bin/prnh/20051221/NYTU092 -- AP
Archive Topic Gallery: http://photoarchive.ap.org/ This photo is
also available via the AP PhotoExpress Network, as PRN4. For more
information on the photo, or on gaining access to the archives,
media may contact the PR Newswire Photo Desk at +1-888-776-6555 or
+1-212-782-2840. PRNewswire -- Dec. 21
http://www.newscom.com/cgi-bin/prnh/20051221/NYTU092
http://photoarchive.ap.org/ DATASOURCE: Bayer Pharmaceuticals
Corporation; Onyx Pharmaceuticals, Inc.
Copyright